223 related articles for article (PubMed ID: 25178770)
1. Patients at risk for contrast-induced nephropathy and mid-term effects after contrast administration: a prospective cohort study.
Moos SI; Nagan G; de Weijert RS; van Vemde DN; Stoker J; Bipat S
Neth J Med; 2014 Sep; 72(7):363-71. PubMed ID: 25178770
[TBL] [Abstract][Full Text] [Related]
2. Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention.
Chong E; Shen L; Poh KK; Tan HC
Singapore Med J; 2012 Mar; 53(3):164-9. PubMed ID: 22434288
[TBL] [Abstract][Full Text] [Related]
3. Contrast Induced Nephropathy and Long-term Renal Decline After Percutaneous Transluminal Angioplasty for Symptomatic Peripheral Arterial Disease.
Sigterman TA; Krasznai AG; Snoeijs MG; Heijboer R; Schurink GW; Bouwman LH
Eur J Vasc Endovasc Surg; 2016 Mar; 51(3):386-93. PubMed ID: 26460289
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of contrast material-induced nephropathy in the era of hydration.
Balemans CE; Reichert LJ; van Schelven BI; van den Brand JA; Wetzels JF
Radiology; 2012 Jun; 263(3):706-13. PubMed ID: 22535561
[TBL] [Abstract][Full Text] [Related]
5. Contrast-induced nephropathy after peripheral vascular intervention: Long-term renal outcome and risk factors for progressive renal dysfunction.
Al Adas Z; Lodewyk K; Robinson D; Qureshi S; Kabbani LS; Sullivan B; Shepard AD; Weaver MR; Nypaver TJ
J Vasc Surg; 2019 Mar; 69(3):913-920. PubMed ID: 30292616
[TBL] [Abstract][Full Text] [Related]
6. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.
Sany D; Refaat H; Elshahawy Y; Mohab A; Ezzat H
Ren Fail; 2014 Mar; 36(2):191-7. PubMed ID: 24138570
[TBL] [Abstract][Full Text] [Related]
7. [Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial].
Nijssen EC; Rennenberg RJ; Nelemans PJ; Essers BA; Janssen MM; Vermeeren MA; van Ommen V; Wildberger JE
Ned Tijdschr Geneeskd; 2018; 161():D1734. PubMed ID: 29328007
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Safety Guidelines on the Use of Iodinated Contrast Material: Conundrum Continued.
Nijssen EC; Nelemans PJ; Rennenberg RJ; van Ommen V; Wildberger JE
Invest Radiol; 2018 Oct; 53(10):616-622. PubMed ID: 29762257
[TBL] [Abstract][Full Text] [Related]
9. Feasibility study of the RenalGuard™ balanced hydration system: a novel strategy for the prevention of contrast-induced nephropathy in high risk patients.
Dorval JF; Dixon SR; Zelman RB; Davidson CJ; Rudko R; Resnic FS
Int J Cardiol; 2013 Jun; 166(2):482-6. PubMed ID: 22204847
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial.
Nijssen EC; Rennenberg RJ; Nelemans PJ; Essers BA; Janssen MM; Vermeeren MA; Ommen VV; Wildberger JE
Lancet; 2017 Apr; 389(10076):1312-1322. PubMed ID: 28233565
[TBL] [Abstract][Full Text] [Related]
11. Remote Ischemic Preconditioning To Reduce Contrast-Induced Nephropathy: A Randomized Controlled Trial.
Menting TP; Sterenborg TB; de Waal Y; Donders R; Wever KE; Lemson MS; van der Vliet JA; Wetzels JF; SchultzeKool LJ; Warlé MC
Eur J Vasc Endovasc Surg; 2015 Oct; 50(4):527-32. PubMed ID: 26015372
[TBL] [Abstract][Full Text] [Related]
12. Incidence and outcomes of contrast-induced nephropathy after computed tomography in patients with CKD: a quality improvement report.
Kim SM; Cha RH; Lee JP; Kim DK; Oh KH; Joo KW; Lim CS; Kim S; Kim YS
Am J Kidney Dis; 2010 Jun; 55(6):1018-25. PubMed ID: 20097462
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumour necrosis factor receptors 1 and 2 predict contrast-induced nephropathy and progressive renal dysfunction: a prospective cohort study.
An JN; Yoo KD; Hwang JH; Kim HL; Kim SH; Yang SH; Kim JH; Kim DK; Oh YK; Kim YS; Lim CS; Lee JP
Nephrology (Carlton); 2015 Aug; 20(8):552-9. PubMed ID: 25783484
[TBL] [Abstract][Full Text] [Related]
14. Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.
Marenzi G; Ferrari C; Marana I; Assanelli E; De Metrio M; Teruzzi G; Veglia F; Fabbiocchi F; Montorsi P; Bartorelli AL
JACC Cardiovasc Interv; 2012 Jan; 5(1):90-7. PubMed ID: 22230154
[TBL] [Abstract][Full Text] [Related]
15. Incidence of contrast-induced nephropathy in kidney transplant recipients.
Haider M; Yessayan L; Venkat KK; Goggins M; Patel A; Karthikeyan V
Transplant Proc; 2015 Mar; 47(2):379-83. PubMed ID: 25769577
[TBL] [Abstract][Full Text] [Related]
16. Contrast induced nephropathy in patients undergoing intravenous (IV) contrast enhanced computed tomography (CECT) and the relationship with risk factors: a meta-analysis.
Moos SI; van Vemde DN; Stoker J; Bipat S
Eur J Radiol; 2013 Sep; 82(9):e387-99. PubMed ID: 23711425
[TBL] [Abstract][Full Text] [Related]
17. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
Alessandri N; Lanzi L; Garante CM; Tersigni F; Sergiacomi R; Petrassi M; Di Matteo A; Tufano F
Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661
[TBL] [Abstract][Full Text] [Related]
18. Probability of reduced renal function after contrast-enhanced CT: a model based on serum creatinine level, patient age, and estimated glomerular filtration rate.
Herts BR; Schneider E; Obuchowski N; Poggio E; Jain A; Baker ME
AJR Am J Roentgenol; 2009 Aug; 193(2):494-500. PubMed ID: 19620448
[TBL] [Abstract][Full Text] [Related]
19. Clinically significant contrast induced acute kidney injury after non-emergent cardiac catheterization--risk factors and impact on length of hospital stay.
Kashif W; Khawaja A; Yaqub S; Hussain SA
J Coll Physicians Surg Pak; 2013 Dec; 23(12):842-7. PubMed ID: 24304985
[TBL] [Abstract][Full Text] [Related]
20. Contrast-induced nephropathy in patients with active cancer undergoing contrast-enhanced computed tomography.
Hong SI; Ahn S; Lee YS; Kim WY; Lim KS; Lee JH; Lee JL
Support Care Cancer; 2016 Mar; 24(3):1011-7. PubMed ID: 26238629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
